Published in J Am Acad Child Adolesc Psychiatry on January 01, 1996
More on SSRI-induced mania. J Am Acad Child Adolesc Psychiatry (1996) 1.13
Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. Future Neurol (2009) 0.98
SSRI-induced mania. J Am Acad Child Adolesc Psychiatry (1997) 0.78
Clinical review of mania, hostility and suicide-related events in children and adolescents treated with antidepressants. Paediatr Child Health (2005) 0.78
Toward a rational prescribing practice. J Am Acad Child Adolesc Psychiatry (1996) 0.75
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry (2001) 2.74
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol (2000) 1.81
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry (2001) 1.63
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry (1996) 1.58
Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. J Clin Psychiatry (1990) 1.45
Pycnogenol for ADHD? J Am Acad Child Adolesc Psychiatry (1999) 1.42
Anxiolytics, adrenergic agents, and naltrexone. J Am Acad Child Adolesc Psychiatry (1999) 1.39
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry (1997) 1.35
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry (2001) 1.29
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry (2001) 1.25
Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry (2001) 1.14
Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents. J Am Acad Child Adolesc Psychiatry (2000) 1.02
Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry (2001) 1.01
Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: preliminary findings. Am J Psychother (2001) 0.99
Racial differences on the Conners Teacher Rating Scale. J Abnorm Child Psychol (1998) 0.98
Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder. Neuropsychology (1997) 0.86
SSRI for body dysmorphic disorder. J Am Acad Child Adolesc Psychiatry (1997) 0.83
Psychopharmacology of pediatric posttraumatic stress disorder. J Child Adolesc Psychopharmacol (1999) 0.77
Fluoxetine and fluvoxamine in PTSD. Am J Psychiatry (1992) 0.77
Absence of cardiovascular adverse effects of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatry (1999) 0.76
Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder? J Child Adolesc Psychopharmacol (1990) 0.75
Sleep disturbance in PTSD. Am J Psychiatry (1990) 0.75
High-dose olanzapine in an adolescent. J Am Acad Child Adolesc Psychiatry (1999) 0.75
Case report: high plasma level tricyclic antidepressant therapy in children: a case report and commentary. J Child Adolesc Psychopharmacol (1993) 0.75
Fluoxetine-TCA interaction. J Am Acad Child Adolesc Psychiatry (1990) 0.75